PATENT CLAIM ANALYSIS

Application Number: 15913646
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "183000"]

Abstract:
The present invention pertains to the use for preventing or treating intestinal infections caused by gram-positive bacteria in animals of an antibacterial compound selected from lactylate in accordance with formula 1, R 2 -COO—[—CH(CH 3 )—COO] n —R1   Formula 1 or a Na, K, Ca, Mg, Fe(II), Zn, NH 4 , or Cu(II) salt thereof,a glycolylate of formula 2,  R 2 -COO—[—CH2-COO] n -R1   Formula 2 or a Na, K, Ca, Mg, Fe(II), Zn, NH 4 , or Cu(II) salt thereof, a lactate ester of formula 3,  HO—CH(CH 3 )—COO—R2   Formula 3 and/or a glycolic acid ester of formula 4, HO—CH2—COO—R2   Formula 4 wherein R1 is selected from H, n stands for an integer with a value of 1-10, and R2 stands for a C1-C35 alkyl or alkenyl chain which may be branched or unbranched. The compound, which preferably is a lactylate or a Na, K, Ca, Mg, Fe(II), Zn, NH 4 , or Cu(II) salt thereof, is particularly useful in the treatment or prevention of  Clostridia . An animal nutrition composition and a method for preventing or treating infections are also claimed.

Claim (Index 19):
The method according to  claim 15 , wherein n of the compound is 1, 2, or 3.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 2.36893
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14390877', '14131216', '14044546', '13406202', '12586359']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.780556140003667
- 35 USC 102 Novelty (BERT): 0.5205426415587369
- Combined Prediction Score: 0.754554790159174
- Mean Citation Score: 225.98586
- Max Citation Score: 281.7313
- Similarity Product: 176.16916516668198

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test